Journal of Psychosomatic Research
Volume 63, Issue 6 , Pages 617-623 , December 2007

Quality of life among patients with a brain tumor and their carers

Received 18 January 2007 ,Revised 30 April 2007 ,Accepted 20 June 2007.

References 

  1. Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In:  De Vita VT,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. Philadelphia: Lippinott Willimas & Wilkins; 2001;p. 2100–2160
  2. Norden AD, Wen PY. Glioma therapy in adults. Neurologist. 2006;12:279–292
  3. Oertel J, von Buttlar E, Schroeder HW, Gaab MR. Prognosis of gliomas in the 1970s and today. Neurosurg Focus. 2005;18:e12
  4. Efficace F, Bottomley A. Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol. 2003;4:11–12
  5. Bampoe J, Laperriere N, Pintilie M, Glen J, Micallef J, Bernstein M. Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg. 2000;93:917–926
  6. Schmidinger M, Linzmayer L, Becherer A, Fazeny-Doemer B, Fakhrai N, Prayer D, et al. Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol. 2003;63:55–61
  7. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75:1151–1161
  8. Cella D. FACIT manual. In: Center on Outcomes, Research and Education. Evanston Northwestern Healthcare and Northwestern University, Version 4; 1997;
  9. Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A, et al The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579
  10. Brucker P, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy–General (FACT-G). Eval Health Prof. 2005;28:192–211
  11. Koot RW, de Heer K, Oort FJ, Hulshof MC, Bosch DA, de Haes JC. Quality of life after brachytherapy in patients with glioblastoma multiforme. Eur J Cancer. 2004;40:1013–1020
  12. McCarter H, Furlong W, Whitton AC, Feeny D, DePauw S, Willan AR, et al. Health status measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol. 2006;24:3636–3643
  13. Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358–366[discussion 366–7]
  14. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry. 2006;21:194–199
  15. Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005;56:1234–1241[discussion 1241–2]
  16. North CA, North RB, Epstein JA, Piantadosi S, Wharam MD. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer. 1990;66:6–14
  17. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41–49
  18. Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516–521
  19. Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76:562–568
  20. Gilbert M, Armstrong T, Meyers C. Issues in assessing and interpreting quality of life in patients with malignant glioma. Semin Oncol. 2000;27:20–26
  21. Taphoorn MJ. Neurocognitive sequelae in the treatment of low-grade gliomas. Semin Oncol. 2003;30:45–48
  22. Kim Y, Baker F, Spillers RL, Wellisch DK. Psychological adjustment of cancer caregivers with multiple roles. Psychooncology. 2006;15:795–804
  23. Mor V, Allen SM, Siegel K, Houts P. Determinants of need and unmet need among cancer patients residing at home. Health Serv Res. 1992;27:337–360
  24. Pahlson A, Ek L, Ahlstrom G, Smits A. Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol. 2003;65:149–158
  25. Salander P, Spetz A. How do patients and spouses deal with the serious facts of malignant glioma?. Palliat Med. 2002;16:305–313
  26. Horowitz S, Passik SD, Malkin MG. “In sickness and in health”: a group intervention for spouses caring for patients with brain tumors. J Psychosoc Oncol. 1996;14:43–56
  27. Fang CY, Manne SL, Pape SJ. Functional impairment, marital quality, and patient psychological distress as predictors of psychological distress among cancer patients' spouses. Health Psychol. 2001;20:452–457
  28. Manne SL, Pape SJ, Taylor KL, Dougherty J. Spouse support, coping, and mood among individuals with cancer. Ann Behav Med. 1999;21:111–121
  29. Northouse LL, Mood D, Templin T, Mellon S, George T. Couples' patterns of adjustment to colon cancer. Soc Sci Med. 2000;50:271–284
  30. Janda M, Eakin EG, Bailey L, Walker D, Troy K. Supportive care needs of people with brain tumours and their carers. Support Support Care Cancer. 2006;14:1094–1103
  31. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41
  32. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  33. Skarstein J, Bjelland I, Dahl AA, Laading J, Fossa SD. Is there an association between haemoglobin, depression, and anxiety in cancer patients?. J Psychosom Res. 2005;58:477–483
  34. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77
  35. Sloan JA, Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol. 2005;58:1217–1219
  36. Salo J, Niemela A, Joukamaa M, Koivukangas J. Effect of brain tumour laterality on patients' perceived quality of life. J Neurol Neurosurg Psychiatry. 2002;72:373–377
  37. Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolbers JG, et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry. 1992;55:372–376
  38. Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76:283–291
  39. Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19:4037–4047
  40. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005;103:841–847
  41. Weitzner MA, Meyers CA. Quality of life and neurobehavioural functioning in patients with malignant gliomas. Baillieres Clin Neurol. 1996;5:425–439
  42. Rogers MP, Orav J, Black PM. The use of a simple Likert scale to measure quality of life in brain tumor patients. J Neurooncol. 2001;55:121–131
  43. Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neurooncology. 2000;2:221–228
  44. Walker M, Brown J, Brown K, Gregor A, Whittle IR, Grant R. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol. 2003;63:179–186
  45. Jones LW, Guill B, Keir ST, Carter BSK, Friedman HS, Bigner DD, et al. Patterns of exercise across the cancer trajectory in brain tumor patients. Cancer. 2006;106:2224–2232
  46. DiSipio T, Rogers C, Newman B, Whiteman D, Eakin E, Fritschi L, et al. The Queensland Cancer Risk Study: behavioural risk factor results. Aust N Z J Public Health. 2006;30:375–382

PII: S0022-3999(07)00250-4

doi: 10.1016/j.jpsychores.2007.06.018

Journal of Psychosomatic Research
Volume 63, Issue 6 , Pages 617-623 , December 2007